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Abstract
Injectable hydrogels present several advantages over prefabricated scaffolds including ease of 
delivery, shear-thinning property, and broad applicability in the fields of drug delivery and tissue 
engineering. Here, we report an approach to develop injectable hydrogels with sustained drug 
release properties, exploiting the chemical nature of the DNA backbone and silicate nanodisks. A 
two-step gelation method is implemented for generating a combination of noncovalent network 
points, leading to a physically cross-linked hydrogel. The first step initiates the development of an 
interconnected structure by utilizing DNA denaturation and rehybridization mechanism to form 
hydrogen bonds between complementary base pairs of neighboring DNA strands. The anisotropic 
charge distribution of two-dimensional silicate nanodisks (nSi) makes them an active center in the 
second step of the gelation process. Silicate nanodisks create additional network points via 
attractive electrostatic interactions with the DNA backbone, thereby enhancing the mechanical 
resilience of the formulated hydrogel. The thermally stable hydrogels displayed an increase in 
elasticity and yield stress as a function of nSi concentration. They were able to form self-
supporting structures post injection due to their rapid recovery after removal of cyclic stress. 
Moreover, the presence of nanosilicate was shown to modulate the release of a model osteogenic 
drug dexamethasone (Dex). The bioactivity of released Dex was confirmed from in vitro 
osteogenic differentiation of human adipose stem cells and in vivo bone formation in a rat cranial 
bone defect model. Overall, our DNA-based nanocomposite hydrogel obtained from a 
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combination of noncovalent network points can serve as an injectable material for bone 
regeneration and carrier for sustained release of therapeutics.
Graphical Abstract
Keywords
nanocomposites; DNA; two-dimensional nanosilicates; physical cross-linking; injectable 
hydrogels; controlled release
Physically cross-linked injectable hydrogels are three-dimensional networks where the 
polymeric chains are held together through noncovalent interactions such as electrostatic 
forces, hydrogen bonds, and hydrophobic interactions.1-3 They have been extensively 
investigated for biomedical and pharmaceutical applications due to their noninvasive nature 
and advantages with respect to chemically conjugated networks. The primary advantage of 
physical hydrogels is their ability to form an interconnected structure without the need of 
any toxic cross-linking agents which can hinder the biological activity of encapsulated 
biomolecules or pose biocompatibility issues. Shear-thinning physical hydrogels can easily 
be injected using a fine gauge needle, and gelation can occur almost instantly following 
injection owing to their ability to reassemble after the removal of the shear force. Hence, 
these materials have become increasingly important for bone regenerative applications, 
particularly for cranial repair.4,5 Currently, available treatment methods largely depend on 
invasive techniques, where the biomaterials are surgically placed in the bone defect sites.4 
On the contrary, injectable materials offer the advantage of direct delivery into the defect site 
along with entrapped therapeutics. From a clinical perspective, minimally invasive 
procedures lower the risk of infection, reduce the extensive blood loss, and avoid surgical 
scar formation. Furthermore, injectable hydrogels can fill up any desired shape and hence 
can be used to treat irregular defects in contrast to prefabricated scaffolds.
Natural polysaccharides and proteins such as alginate, hyaluronic acid, chitosan, gelatin, or 
collagen have been extensively investigated for the preparation of injectable hydrogels due 
to their higher biocompatibility when compared to that of synthetic polymers.1,6,7 However, 
in most of the cases, there is a need for an extra functionalization step or the addition of a 
second polymer to introduce a reactive building block for physical cross-linking.1,8-10 A 
more advanced strategy to produce injectable hydrogel is by selection of polymers that can 
self-assemble into defined structures due to the presence of specific molecular recognition 
motifs. DNA is a natural biopolymer, and there is an immense potential for treating DNA as 
a chemical entity instead of a genetic material. DNA possesses many desirable properties 
such as high molecular weight and presence of available chemical functionalities on the 
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backbone for chemical and physical bonding to other bioactive substances.11-13 
Additionally, the base-pairing interactions are highly specific, leading to the well-known 
double-helix structure. Given these features, DNA can be employed for the fabrication of 
injectable hydrogels for biomedical applications. Several mechanisms have been explored to 
design DNA-based hydrogels, including ligase-mediated reactions, combination with 
cationic materials or ionic liquids, covalent bond formation, and complementary base 
pairing.12,14-18 However, only a few reports have investigated the possibility to form 
injectable hydrogels by exploring the inherent noncovalent interactions of DNA.19-21
Recent studies have shown the potential of nanosilicates to form a physically cross-linked 
network via noncovalent interactions with various polymers.22,23 Nanosilicates (Laponite 
XLS) are two-dimensional (2D) disk-shaped synthetic silicates with a diameter of 20–30 nm 
and thickness of ~1 nm.24-26 They have anisotropic charge distribution on their surface that 
can be leveraged for their interaction with phosphate groups of the DNA backbone. 
Specifically, the edges of the silicate nanodisks (nSi) have positive charge, whereas the top 
and bottom surfaces are negatively charged.27 Thus, they can form reversible electrostatic 
bonds with charged polymers which can dynamically form and break. This phenomenon 
makes nSi an ideal candidate to be used in the design of shear-thinning injectable hydrogels. 
The reversible nature of the electrostatic bonds allows for immediate recovery after 
injection, thereby restoring the prestrained moduli upon removal of shear. Hence, nSi can be 
used as a component in the DNA-based hydrogel to assist the formation of a three-
dimensional (3D) network via electrostatic interactions. No previous study has focused on 
harnessing the anisotropic charge distribution of nanosilicates for the fabrication of DNA-
based injectable hydrogels. Additionally, due to the aforementioned properties, silicate 
nanodisks can modulate the release of bioactive molecules including drugs, proteins, and 
vaccines.28 For instance, the high surface area and the presence of anisotropic charges 
enable the high loading efficiency and the sustained release of bioactive molecules including 
antigens.
Herein, we report the formation of an injectable hydrogel based on DNA and silicate 
nanodisks that can be prepared by a facile technique of heating and mixing. The proposed 
strategy presents the advantage of developing physically cross-linked networks without the 
need of chemical modification of the DNA backbone or design of specific DNA base 
sequences. The formulated hydrogel is created by the combination of two different types of 
network points: type A, interconnections between neighboring DNA strands induced by the 
heating step; type B, linkages due to the interaction between nSi and the DNA backbone. We 
examined the effect of nSi on shear-thinning and injectability properties of the hydrogel by 
investigating the rheological behavior of different formulations. Additionally, the specific 
electrostatic interactions between nSi and DNA, responsible for the network formation, were 
thoroughly investigated using X-ray photoelectron spectroscopy (XPS) analysis. Finally, as a 
proof of concept, the ability of the formulated nanocomposite hydrogels to modulate the 
release of the model drug dexamethasone (Dex) was monitored in vitro. We envision that the 
developed DNA-based nanocomposite hydrogel has the potential to be used in a broad range 
of biomedical applications, such as injectable hydrogels for tissue regeneration, drug-eluting 
functional coatings, sustained drug delivery vehicles, and bioinks for tissue engineering.
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Shear-Thinning Injectable DNA–nSi Nanocomposite Hydrogels with a Porous Structure.
In this study, DNA is used as the base polymer to form physical hydrogels. A fundamental 
structural characteristic of DNA is the specific base-pairing interactions. These interactions 
were exploited in the first step of thermal gelation, by promoting the base pairing among 
adjacent strands of DNA (Figure 1). As the first step, a 4% (w/v) DNA solution in water was 
heated at 90 °C for different time intervals ranging from 30 s to 30 min followed by a 
cooling step at 37 °C. DNA concentrations lower than 4% (w/v) were not studied as the 
sample analysis led to inconsistent results. A temperature of 90 °C is required to denature 
the double helix of DNA, by breaking hydrogen bonds between complementary base pairs.29 
The subsequent cooling phase is necessary to allow the rehybridization of the DNA strands 
in a random conformation through interactions with base pairs of neighboring strands. The 
whole process leads to the formation of an interconnected structure (type A network) that 
exhibits different properties when compared to the original DNA solution that did not 
undergo the heating—cooling treatment.
We monitored the physical changes in the different systems by performing rheological 
measurements on the samples to detect the most suitable heating time. The goal of this part 
of the study was to identify the optimum heating interval required to obtain an intermediate 
weak DNA-based network (pregel) that could be mixed with nSi to form the nanocomposite 
hydrogel (Figure 1). An increase in the duration of the heating step induced a change of the 
DNA solutions from a sol (G″ > G′) to a gel state (G′ > G″) (Figure S1a). Oscillatory 
shear rheology confirmed the formation of a solid-like material (G′ > G″) for heating times 
longer than 30 s. Precisely, the analysis of the tan δ profiles, which is defined as the ratio of 
loss modulus (G′′) to storage modulus (G′), displayed a constant decrease of this parameter 
with prolonged heating times (Figure S1b). At short heating times corresponding to 30 s, the 
supplied heat energy was not sufficient enough to unwind a substantial section of the DNA 
strand. Hence, this formulation displayed tan δ values greater than 1, indicative of a liquid-
like material (G″ > G′) with similar properties to the DNA solution that did not receive any 
thermal treatment. On the contrary, tan δ values below 1 indicate the formation of a cross-
linked network, and the lower is this parameter, the more interconnected is the 
corresponding hydrogel. Additionally, frequency sweeps carried out in the frequency range 
of 0.01 to 10 Hz showed an increase in the G′ values from 99 to 460 Pa at 1 Hz 
corresponding to the samples heated for 30 s and 30 min, respectively. However, the G′ 
profile for the 30 s sample was different from the other systems since this formulation was in 
a sol state, and thus the G′ values were strongly affected by the frequency applied (Figure 
S1c). These data demonstrate a direct relationship between the degree of network cross-
linking and the duration of the heating step. A heating time of 45 s was sufficient enough to 
form a weak DNA-based gel (G′ > G″), and this parameter was kept constant in the 
following optimization studies. Longer heating intervals were not selected as the 
corresponding gels were too cross-linked to be mixed with nSi.
To further confirm the formation of an interconnected network with a heating process of 
only 45 s, we investigated the difference in viscosity following the thermal treatment. An 
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increase in viscosity was observed in the whole range of investigated shear rates, which 
supports the hypothesis of structural changes occurring in the DNA solution during the 
process of pregel formation (Figure S2a). Furthermore, absorbance measurements of the 
DNA solution before and after 45 s of heating confirmed the separation of the DNA strands 
during the heating phase (Figure S2b,c). Both groups exhibited a maximum absorbance at 
~260 nm because of the electronic structure of purine and pyrimidine bases present in DNA.
30 However, the absorbance of the pregel at 260 nm was slightly higher than that of the 
starting DNA solution. This change is likely due to the DNA strand separation leading to the 
partial unwinding of the DNA double helix during the heating cycle. After the 
rehybridization step occurring during the cooling phase, some of the base pairs end up 
remaining free, which in turn are responsible for the increase in absorbance detected at 260 
nm.29 These combined results indicate the successful formation of a pregel structure.
In the second step, different concentrations of nSi dispersions were mixed with the 
optimized pregel formulation to form the nanocomposite DNA-based hydrogel (Figure 1b). 
Silicate nanodisks are 20–25 nm in diameter, as confirmed using transmission electron 
microscopy (TEM) (Figure 2a). The anisotropically charged two-dimensional, ultrathin 
structure of nSi (1–2 nm) with high surface-to-volume ratio facilitates the physical 
interaction of the nanodisks with the DNA matrix to form physically cross-linked hydrogels 
via the development of type B network points.31 nSi was dispersed in Milli-Q water and 
vortexed to form an exfoliated dispersion with a high surface area, before inclusion into the 
DNA pregel. Thereafter, the nSi dispersion was added to the pregel at room temperature 
followed by a vigorous vortexing treatment to prevent the aggregation of the nanosilicate 
disks. Nano-composite hydrogels were developed consisting of three different nSi 
concentrations ranging from 0.1 to 0.5% (w/v) labeled as 0.1% nSi, 0.25% nSi, and 0.5% 
nSi. All of the formulated DNA—nSi physically cross-linked hydrogels could be easily 
injected using a 22 gauge needle (Figure 2b and Movie S1) due to their shear-thinning 
behavior (Figure 2c). This property is an essential requisite for injectable hydrogels as they 
should be able to flow with increasing shear rates.32
The interaction between the DNA backbone and nSi was detected by monitoring the 
viscosity of the hydrogel formulations as a function of shear rate starting from 0.001 to 1000 
s−1. As the concentration of nSi was increased, a corresponding change in viscosity was 
monitored (Figure 2c). As expected, an increase in the concentration of nSi resulted in an 
increment in viscosity, which is commonly observed for nSi-based nanocomposite systems. 
Additionally, we investigated the porosity of the hydrogels as this parameter can affect the 
drug release capabilities of the formulated injectable hydrogels. The DNA system without 
any silicate possesses a highly porous interconnected structure, as observed by scanning 
electron microscopy (SEM) analysis. The inclusion of nSi caused a reduction in the porosity 
of the hydrogel, which is indicative of a more compact network with a higher degree of 
physical cross-linking (Figure 2d). Specifically, the incorporation of nSi at 0.5% (w/v) 
caused a significant reduction in the average pore diameter from 20.22 to 10.81 μm (Figure 
2e). These findings are consistent with previous reports focused on the characterization of 
nSi-based nanocomposite hydrogels.33 Further analysis of the internal porosity was obtained 
by performing a microcomputed tomography (microCT) analysis, which can better display 
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the interconnected three-dimensional porous structure of the nanocomposite hydrogel 
compared to SEM analysis (Movie S2).
The presence of nSi in the hydrogel was detected via energy-dispersive X-ray spectroscopy 
(EDX). The EDX spectra of 0% nSi (Figure 2f) showed the peaks corresponding to carbon, 
nitrogen, oxygen, and phosphorus that are the constitutional elements found in the DNA. 
The spectra also displayed an additional peak relative to sodium because the DNA used in 
this study presented phosphate groups coupled with sodium counterions. The EDX spectra 
of the 0.5% nSi system showed the presence of Mg and Si signals, which are the major 
components of silicate nanodisks (Figure 2g). The presence of nSi in the cross-linked 
hydrogel network was further confirmed by XPS (Figure 2h). The peak at ~100 eV 
corresponded to Si 2p, which was absent in the system with 0% nSi.34 Overall, these results 
indicate the successful formation of an injectable shear-thinning nanocomposite hydrogel 
which displays a porous structure.
Mechanical and Structural Characterization of Shear-Thinning Hydrogels.
Oscillatory shear rheology was performed to investigate the effect of nSi on the mechanical 
properties of the nanocomposite DNA-based hydrogel. Preliminary strain sweep 
measurements were carried out to detect the linear viscoelastic (LVE) region of each sample. 
Subsequently, frequency sweep analysis was performed in the LVE region at frequencies 
ranging from 0.01 up to 10 Hz. The pregel formulation (0% nSi) exhibited the highest values 
of tan δ, and a corresponding decrease in this parameter was observed as the concentration 
of nSi was increased (Figure 3a). These results can be attributed to the ability of the 
nanosilicate to form a physically cross-linked network when combined with DNA. Silicate 
nanodisks interact electrostatically with the negatively charged phosphate groups of the 
DNA backbone due to the presence of positive charges on its edges.27,35 These interactions 
modulate the elasticity of the nanocomposite hydrogel, and the formation of a large number 
of these network points can be responsible for the observed increase in the storage moduli 
values (Figure 3b).
An injectable material should form self-supporting structures following injection, which 
allows the hydrogel to remain in the defect area without flowing away into adjacent sites. 
Hence, we investigated the effect of nSi in modulating the yield stress of the DNA-based 
hydrogels. Yield stress was defined as the crossover point between G′ and G″ in the 
oscillatory shear stress sweeps.36 An increase in the yield stress from 29.45 ± 3.75 to 73.98 
± 9.42 Pa was observed with an increase in the nSi concentration from 0 to 0.5%, 
respectively (Figure 3c). The observed increment is likely due to the reinforcement of the 
DNA network induced by the dispersed nanosilicate. Upon injection, the nanocomposite 
hydrogel was capable of retaining its shape when compared to the starting DNA solution 
(Figure S3a). Such an effect has been reported in similar studies investigating the influence 
of nSi on the mechanical properties of polymeric nanocomposite hydrogels.37 No significant 
change in the values of yield stress was detected when the temperature was varied from 25 to 
37 °C for all the formulations (Figure S3b). This result indicates that each one of the 
designed DNA-based nanocomposite hydrogels possesses thermal stability and can be 
injected without losing its structural integrity as the temperature increases. However, the 
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system containing 0.5% w/v nSi exhibited the highest yield strength and elasticity, and this 
formulation was chosen as the optimal group for further testing. Hydrogels with nSi 
concentrations greater than 0.5% w/v were not studied as the starting nSi dispersions were 
too viscous to attain a uniform distribution of the nanodisks in the pregel matrix.
Another essential aspect to consider while designing injectable nanocomposite hydrogels is 
to verify whether the material can sustain cyclic strain and regain its original structure once 
the shear strain is removed. Oscillatory strain amplitude studies were carried out by applying 
two consecutive cycles of high (100%) and low (1%) strain. The variation of the storage 
modulus (G′) was monitored, and complete recovery of G′, within seconds, was observed 
for both the formulation with and without the nanosilicate (Figures 3d and S3c). However, a 
higher value of G′ was detected for the nanocomposite system. Overall, the formulated 
physically cross-linked network exhibited rapid recovery and restoration of the storage 
modulus following the removal of stress. Additionally, the hydrogel containing 0.5% nSi 
maintained its elastic properties as the temperature was increased from 25 to 45 °C (Figure 
3e). These data confirmed the stability of the formulated nanocomposite hydrogel over a 
wide range of temperatures that the sample might experience during storage and post 
injection in vivo. All the advantages mentioned so far were possible using a relatively low 
concentration of silicate nanodisks (0.5% w/v) as compared to other nanocomposite systems 
containing nSi.38,39 Using a lower concentration of nanosilicate can also be beneficial to 
reduce the possible cytotoxic effects.40
Finally, we compared the rheological properties of the nanocomposite hydrogels with and 
without the preliminary heating step to evaluate the effect of thermal energy on the gel 
strength, elasticity, and self-healing properties. The unheated sample formed by mixing both 
DNA and nSi is composed of only type B network points (Figure S4a). The storage modulus 
(G′) of the unheated sample was higher than the one that did not undergo a preliminary 
heating step (Figure S4b). Despite the higher G′ values, the relatively similar tan δ for both 
the groups indicated a higher loss modulus for the unheated sample compared to that of the 
heated one (Figure S4c). This can be attributed to the absence of the base network of 
interconnected DNA strands (type A network points) in the unheated sample. The heating 
step guarantees the formation of a more stable and flexible network that displayed higher 
yield stress (Figure S4d) and a faster recovery of its original storage moduli values (Figure 
S4e). Additionally, the absence of a preheating step caused a reduction in the percentage of 
recovery which was only equal to 60% of the original G′ values for the unheated 
formulation (Figure S4f). Hence, it was confirmed that the initial heating step imparts a 
profound beneficial effect on the gel mechanical properties. The interconnections with 
neighboring DNA chains in the pregel are not sufficient to form a stable gel, but these 
preliminary linkages (type A network points) are necessary to maximize the strength and the 
elasticity of the hydrogel. Overall, the difference in rheological responses of the 
nanocomposite hydrogels provides conclusive evidence that both the heating step and 
addition of nSi assisted in the formation of a mechanically resilient elastic hydrogel, 
resulting from a combination of type A and type B network points.
To identify the electrostatic interactions between nSi and the DNA backbone, Fourier 
transform infrared spectroscopy (FTIR) was carried out on the samples with and without the 
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nanosilicate. Pure DNA hydrogels exhibited asymmetric stretching vibrations of a phosphate 
group (PO2−) at 1241 cm−1 and O─P─O bending vibration at 963 cm−1 (Figure 3f). Both 
bands are characteristic spectral signatures of a double-stranded DNA structure.41-43 
However, a red shift of the PO2- asymmetric stretching to 1236 cm−1 as well as the decrease 
in the peak intensity was observed upon addition of nSi. Moreover, the disappearance of the 
sharp peak at 963 cm−1 corresponding to the bending of phosphate anion suggested a 
possible change in the molecular environment. The observed results were consistent with 
previous studies reporting the interaction of DNA with various cationic elements.43 These 
findings indicate the binding of the positive edges of nSi with the phosphate group in the 
DNA backbone, which was further confirmed via XPS.
Electrostatic Interactions of Silicate Nanodisks with the DNA Backbone for Hydrogel 
Formation.
XPS studies were performed to validate the type of interactions between DNA and nSi and 
interpret the function of nSi in reinforcing the DNA-based hydrogel network. XPS spectra of 
oxygen (O 1s), phosphorus (P 2p), and nitrogen (N 1s) were recorded to evaluate the 
differences between the two formulations with and without nSi. Differences in peak shapes 
and peak width were found by comparing the O 1s spectrum of the DNA network (0% nSi) 
and the nanocomposite hydrogel (0.5% nSi) (Figure 4a). Similarly, the P 2p peak appeared 
at ~132.8 eV for the 0% nSi sample, whereas a shift of the same peak to higher binding 
energy at ~133.32 eV was observed for the sample containing nSi (Figure 4b). These results 
indicate a change in the electronic environment in the vicinity of oxygen and phosphorus. 
On the contrary, no significant difference was detected in the N 1s peak position and shape 
for the two systems (Figure 4c).
For a better insight, a more detailed analysis was performed by deconvoluting each core 
level spectra into their constituents. A summary of the peak positions for each 
subcomponent and their respective assignment to specific groups of DNA is presented in 
Table S1. The O 1s spectrum was deconvoluted into two components, O1 and O2 (Figure 
4d). O1 at 530.86 eV was assigned to the C═O, P═O, and P─O− groups, whereas the O2 
peak at 533.07 eV corresponded to the C─O─C and C─O─P groups of DNA. The results 
are in agreement with previous XPS reports investigating DNA.44 The O 1s spectrum of the 
nanocomposite hydrogel (0.5% nSi) exhibits an apparent redistribution between the O2 and 
O2 components (Figure 4d). The area under the peak of O1 diminishes with the simultaneous 
increase in the area under the peak for O2. Such an observation can be explained as a shift in 
a fraction of the O1 component to higher binding energy, thereby increasing the area under 
the peak O2. The shift can be attributed to a decrease in electron density in the vicinity of O1 
sites due to the attractive electrostatic interactions with positively charged edges of silicate 
nanodisks.
The presence of attractive electrostatic forces with oxygen was also confirmed by analyzing 
the XPS spectrum of P 2p. The core level P 2p spectrum was split into two spin doubletss, 
P1 and P2, with an area ratio of 2:1, respectively. For 0% nSi sample, P1 at 131.95 eV 
corresponds to P 2p3/2, whereas P2 was assigned to P 2p1/2 at 132.8 eV (Figure 4e). These 
data are consistent with the reported literature.45 The nanocomposite hydrogel (0.5% nSi) 
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exhibited the same peaks P1 and P2, but a shift toward higher binding energies was observed. 
Specifically, an increase in binding energy by 0.5 and 0.52 eV was detected for P1 and P2 
peaks, respectively (Figure 4e). The electrostatic attraction between the electropositive 
region of nSi with the negatively charged oxygen of the phosphate group destabilizes the 
electronic environment of the nearest phosphorus atom. This leads to a decrease in electron 
density around phosphorus, resulting in the increment of binding energies.46 Similar effects 
are described for complexes of DNA-like molecules with cations such as Ce4+.47
To rule out the possibility of strong interaction of nSi with the nitrogenous bases of DNA, 
we compared the deconvoluted N 1s spectra for both systems. The core level N 1s was 
deconvoluted into two peaks, N1 and N2, originating due to the different chemical 
environment of the nitrogen atoms. The N1 peak was assigned to the nitrogen atoms of 
C═N─C and C─NH2 groups corresponding to a binding energy of 398.05 eV (Figure 4f). 
Additionally, the peak of N2 at 399.33 eV was generated from the nitrogen atoms present in 
N─C─O and N─C═O functionalities.44 There was no substantial change in the peak 
distributions of N1 and N2 upon introduction of nSi, indicating minimum interactions of the 
nanosilicate with the nitrogen atom of the DNA bases (Figure 4f). Overall, the XPS results 
confirmed the presence of attractive electrostatic interactions between nSi and the oxygen 
atom of the phosphate anion (PO2−) in the DNA backbone. The physical cross-linking 
mechanism derived from the XPS results depicts interconnection of neighboring DNA 
strands via silicate nanodisks (Figure 4g). These additional network points are the principal 
rationale for the observed increase in gel strength, elasticity, and yield stress compared to the 
DNA-based gel without nSi.
Several reports have focused on studying the effect of physical interactions between the 
specific binding sites of DNA and metal ions.48,49 Similarly, binding with positively charged 
ions has shown to alter the structure and conformation of DNA.49 To our knowledge, no 
previous study has leveraged the potential of DNA to form three-dimensional network 
structures with nSi.20,50-52 Our study moves a step forward in utilizing the noncovalent 
interactions of DNA to create shear-thinning nanocomposite hydrogels with rapid self-
healing properties.
Multifunctionality of the Biocompatible Hydrogel.
Biocompatibility is a prime requirement for a material to be used in biomedical applications. 
The biocompatibility of nanocomposite hydrogels was assessed by performing an MTS 
assay using human adipose stem cells (hASCs). hASCs were chosen for the in vitro studies 
for their easy accessibility and rapid rate of proliferation.53,54 hASCs were cultured in 
contact with the hydrogels containing different concentrations of nSi. The positive control 
was represented by cells grown under serum starvation. All the groups treated with the 
formulated hydrogel showed more than 85% cell viability even after 72 h (Figure 5a). No 
significant difference was observed with the incorporation of nSi over time. Live–dead assay 
performed after 24 h of gel treatment confirmed the MTS results, thus supporting the 
biocompatibility of the nanocomposite hydrogels (Figure S5a). Our results are consistent 
with previous studies, which have shown that nSi induces minimum cytotoxic effects.37
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Furthermore, the influence of nSi on cell morphology and spreading was monitored over a 
period of 72 h. The morphology of hASCs was similar in all the groups after 24 and 72 h 
post-treatment (Figures 5b and S5b,c). In summary, the in vitro studies demonstrated that the 
nanocomposite hydrogels induce minimum cytotoxic effects and do not hinder cell 
spreading. These data strengthen their potential use as multifunctional hydrogels in 
regenerative medicine.
We anticipated that the formulated hydrogels could also function as sustained drug delivery 
vehicles and bioactive coatings in addition to their application as injectable hydrogels in 
minimally invasive therapies. To validate this concept, we encapsulated an osteogenic model 
drug Dex within the hydrogel and monitored its release over a period of 10 days.55
The release rate from the DNA-based hydrogel was observed to decrease with a higher 
concentration of nSi (Figure 5c). The half-life time of the release (t1/2) is defined as the time 
at which 50% of the drug is released from the hydrogel. An increase in t1/2 from 2.5 to 5.5 
days with the increment in nSi concentration from 0 to 0.5% implies enhanced retention of 
Dex in the nSi containing hydrogels (Figure 5d). Extended-release times for the 
nanocomposite hydrogels can be attributed to their compact structure with reduced pore 
diameter compared to the pristine DNA-based hydrogels (0% nSi). As a comparison, we 
investigated the release profile of Dex from a gelatin—nSi hydrogel containing nSi at the 
concentration of 0.5% w/v. The amount of gelatin was optimized to obtain a gel with a 
viscosity comparable to that of the best performing DNA-based nanocomposite hydrogel 
(0.5% nSi) (Figure S6a). The gelatin-based hydrogel released approximately 80% of the 
loaded drug within 2 days, resulting in a much lower half-life time of release (t1/2 = 1.3 
days) as compared to that of the DNA-based system (t1/2 = 5.5 days) (Figure S6b,c).
Finally, the DNA-based hydrogel formulations maintained their shear-thinning properties 
even after the drug loading, confirming their potential as injectable drug delivery systems 
(Figure 5e).
Aside from being injectable and demonstrating controlled drug release properties, the 
designed nanocomposite system can be successfully used as a bioactive coating. 
Specifically, as a proof of concept, the nanocomposite hydrogel was used to coat a human 
bone allograft isolated from the hip region (Figure 5f). Recent studies have demonstrated 
that the process of osteointegration of a bone allograft into the host tissue can be accelerated 
by the application of bioactive hydrogel coatings.56 These coatings can help promote the 
release of drugs or growth factors, as well as modulate the recruitment and osteogenic 
differentiation of host stem cells.57,58 Ideally, the formulated hydrogel can then act as a 
drug-eluting bioactive layer to enhance the therapeutic efficacy of bone allografts. SEM 
analysis of the uncoated and coated allografts revealed the uniform coverage of the 
microporous graft surface by the nanocomposite DNA-based hydrogel. The hydrogel coating 
started to erode away after being soaked in a phosphate buffer solution at pH 7.4, as 
evidenced by SEM analysis, thereby restoring the innate porous framework of the allograft 
(Figure 5g). Furthermore, the formulated nanocomposite hydrogel could be successfully 
bioprinted into defined geometries (Figure S7). However, careful selection in the 
concentration of DNA and the silicate nanodisks are the main key parameters that can 
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influence the reproducibility of bioprinting. Future work in this direction would involve the 
enhancement of mechanical integrity of the bioink in order to inhibit pore collapse while 
printing three-dimensional complex structures with high resolution.39 Additionally, the high 
costs of the DNA extraction process and the limited amount of DNA that can be extracted 
are major issues that can limit the scalability of the bioprinting process.
To conclude, these promising data indicate that the designed injectable nanocomposite 
hydrogel could be potentially used as a multifunctional platform to modulate the release of 
osteogenic drugs or act as bioprinting ink as well as a coating for bone allografts.
Preserved Bioactivity of the Entrapped Drug: Modulation of in Vitro and in Vivo 
Osteogenic Differentiation.
Aside from modulating the release of drugs, an efficient delivery vehicle should not induce 
any significant change in the bioactivity of the encapsulated cargo.59-62 To prove the efficacy 
of the released drug, we examined whether the Dex released from the nanocomposite 
hydrogel was still capable of promoting osteogenic differentiation of hASCs. Dex is a well-
known osteogenic drug that stimulates stem cell osteogenic differentiation.55,63 hASCs were 
cultured for 14 days in osteoconductive media (α-MEM, 10% FBS, 1% penicillin/
streptomycin, 50 μM ascorbic acid-2-phosphate, 10 mM β-glycerophosphate) supplemented 
with Dex obtained from the release study. Osteogenic differentiation of hASCs was 
evaluated by monitoring in vitro alkaline phosphatase (ALP) expression and calcium 
deposition after 7 and 14 days of drug treatment. As controls, hASCs were cultured in 
osteoinductive media (positive control), basal media (negative control), and osteoconductive 
media without the Dex (OC). The basal media contains α-MEM, 10% FBS, and 1% 
penicillin/streptomycin, whereas the osteoinductive medium is composed of α-MEM, 10% 
FBS, 1% penicillin/streptomycin, 50 μM ascorbic acid 2-phosphate, 10 mM β-
glycerophosphate, and 10 nM Dex. Both qualitative and quantitative analyses revealed 
significant up-regulation of ALP in the Dex-treated group similar to the positive control 
group (Figure 6a,c). The observed trend was further validated by alizarin red colorimetric 
staining and quantification of the calcified matrix. At both 7 and 14 days, the Dex-treated 
group along with the positive control displayed a greater extent of calcium deposition. This 
resulted in intense alizarin red staining, which supports the osteogenic differentiation of 
stem cells (Figure 6b).
Calcium quantification results provided confirmatory evidence in support of the staining 
images (Figure 6d). Finally, qPCR analysis after 14 days of treatment showed an increased 
upregulation of osteoblast markers in the Dex-treated group, thereby confirming the efficacy 
of the released Dex. Specifically, the fold increase expression of ALP and COLA1 were 
significantly higher in the Dex-treated group (23.23 ± 9.07 and 9.51 ± 2.68, respectively) 
and positive control (43.58 ± 13.78 and 11.93 ± 2.97, respectively) as compared to the other 
two groups (Figure 6e).64,65 However, the difference in gene expression of BGLAP and BSP 
was not statistically significant among the groups as these two markers are expressed in a 
later stage of osteogenic differentiation (Figure S8).66-69 Overall, these findings confirm the 
retention of the osteogenic property of Dex after being released from the nanocomposite 
hydrogel.
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Finally, we assessed the in vivo osteogenic potential of the drug-loaded hydrogel in a rat 
cranial defect model (Figure 6f). Three different groups (n = 6) were tested including 
untreated rats (untreated), rats receiving the gel without any Dex (gel), and animals treated 
with the drug-loaded gel formulation (gel + Dex). Hematoxylin and eosin (H&E) staining 
was used to evaluate the formation of new bone within the defect after 4 weeks postsurgery. 
The untreated group showed the presence of soft tissue in the defect region without the 
formation of new bone (Figure 6g). On the contrary, small amounts of new bone were 
observed in the central defect region for both gel and gel + Dex groups (Figure 6g). The 
formation of bone in the gel group could be attributed to the presence of nanosilicate, which 
can promote in vitro osteogenic differentiation of stem cells.40 However, the limited bone 
regeneration capability shown by the Dex-loaded hydrogels could be ascribed to several 
factors including the short time frame of the study or the lack of additional osteogenic and 
angiogenic growth factors co-delivered in the defect area. To enhance the regenerative 
potential of the designed DNA-based hydrogel for cranial defect repair, further optimization 
regarding the type and dosage of possible growth factors, such as BMP-2, BMP-7, and 
VEGF, should be investigated.
CONCLUSION
We have successfully designed a shear-thinning DNA—nSi nanocomposite hydrogel with 
rapid self-healing properties. Silicate nanodisks electrostatically interact with the negatively 
charged phosphate backbone of DNA, thereby enhancing the physical and mechanical 
properties of the hydrogel. The physical crosslinking introduced by nSi resulted in an 
injectable hydrogel with increased structural integrity, elasticity, and thermal stability. The 
formulated nanocomposite hydrogels were also biocompatible and exhibited sustained 
release of the model drug Dex likely due to the reduced internal porosity induced by the 
inclusion of nSi. The drug maintained its bioactivity after release as confirmed by in vitro 
osteogenic differentiation studies of hASCs. Furthermore, the hydrogel was tested as a 
coating to prove its suitability as a drug-eluting degradable layer to modulate the surface 
properties of bone allografts, without sacrificing the long-term graft architecture. 
Preliminary studies were carried out in vivo by injecting the fabricated hydrogels in a rat 
cranial defect model showing minimal bone regeneration, which was observed mainly in the 
group containing Dex. Overall, the presented findings demonstrate an encouraging future for 
the formulated mechanically resilient DNA-based nanocomposite hydrogels as a class of 
injectable materials for diverse biomedical applications such as controlled drug delivery, 
tissue regeneration, and 3D bioprinting.
To further advance the applicability of the formulated hydrogel as a drug delivery system for 
bone regeneration, it is important to validate the suitability of this platform for the release of 
larger molecules including growth factors and proteins involved in the process of bone 
repair. Additionally, the possible in vivo inflammatory response, which plays a major role in 
the process of bone healing, needs to be thoroughly investigated for successful 
implementation of the material for future applications in a clinical setting.
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Preparation of the Pregel Formulation.
DNA at the concentration of 4% w/v (deoxyribonucleic acid sodium salt from salmon testes, 
Sigma-Aldrich, molecular weight ~1.3 × 106 g/mol, corresponding to ~2000 base pairs) was 
first dissolved in Milli-Q water at 35 °C for 2 days.12,13 The solution (300 μL) was then 
heated at 90 °C for 45 s. The pregel was formed by cooling the heated DNA solutions at 
37 °C for 2 h.
Formation of the Nanocomposite Hydrogel.
To prepare nanocomposite hydrogels, the nanosilicates (Laponite XLG, Southern Clay 
Products Inc., USA) were dispersed in Milli-Q water with vigorous agitation (vortexing). 
Then, the nSi dispersions were added to the DNA-based pregel, and the mixture was 
vortexed for 5 min for further dispersion of the nanosilicates in the hydrogel matrix. The 
mixtures were then kept at 37 °C overnight for complete gelation. Three different 
concentrations of nSi (0.1, 0.25, and 0.5% w/v) were tested. The nanocomposite hydrogels 
were stored at 4 °C for further studies. The Dex-loaded hydrogels were formed by adding 
the required amount of the drug to the pregel formulation along with nSi dispersion to 
achieve a concentration of 875 ¼g/mL in the final hydrogel. The concentration of Dex was 
kept constant in all the hydrogels prepared for release studies. Equal volumes of a 14% (w/v) 
gelatin solution and 1% (w/v) nanosilicate dispersion were mixed together in order to form 
the gelatin-based hydrogels for a comparison of Dex release profiles. The Dex-loaded 
gelatin-based hydrogels were prepared by adding the drug to the gelatin solution along with 
the nSi dispersion to obtain a final concentration of Dex similar to the DNA-based hydrogel 
(0.5% nSi + Dex).
Physical and Chemical Characterization.
High-resolution TEM images of nSi dispersions were obtained using an FEI, Tecnai F20XT, 
USA system. The samples were prepared by placing a drop of nSi dispersion on top of 
carbon-coated 200-mesh copper grids, followed by drying the grids in vacuum for a few 
hours. The surface morphology of the nanocomposite hydrogels was evaluated using SEM 
with an in-lens detector, at an acceleration voltage ranging from 1 to 10 kV. The freeze-dried 
nanocomposite hydrogels were sputter coated with gold before being placed on the sample 
holder for imaging. The pore diameters for each group were analyzed using ImageJ software 
from five different images.
Elemental surface chemistry was characterized by EDX using the same samples analyzed by 
SEM. A Bruker Vector-22 FTIR spectrophotometer (PIKE Technologies, USA) was used for 
recording the FTIR spectra of the samples. Freeze-dried samples were mixed with KBr 
(Fischer, USA) and compressed to form a tablet for recording the spectra in the range of 400 
up to 4000 cm−1 (resolution of 1 cm−1). MicroCT analysis of the freeze-dried hydrogel 
samples was performed using a Xradia MicroXCT tomographic X-ray microscope. An X-
ray source of 50 kV was used to obtain a video of three-dimensional porosity of the 
hydrogel at a magnification of 20×.
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All rheological analyses were performed in an AR2000 rheometer (TA Instruments, New 
Castle, DE). Nano-composite hydrogels were tested using a 25 mm steel cone and plate 
geometry, and a water trap was placed on the geometry to avoid excessive evaporation 
during the test. Viscosity measurements were performed at 25 °C, at shear rates ranging 
from 0.001 to 1000 s−1. Frequency sweeps in the range from 0.01 up to 10 Hz were recorded 
for all samples at 25 °C in the linear viscoelastic region at 1% of strain. Preliminary strain 
sweep tests were carried out in the range of 0.1 up to 100% of strain to define the range of 
viscoelastic region. Yield stress was evaluated by conducting oscillatory stress sweep 
measurements at 1 Hz from 0.1 to 200 Pa. The yield stress is identified as the crossover 
point where G″ exceeds the value of G′. Recovery experiments were performed by 
monitoring the G′ and G′′ at 1 Hz by applying 100% strain for 5 min followed by 1% 
strain for 5 min. Finally, temperature sweeps were conducted at a frequency of 1 Hz in the 
range of 25 to 45 °C with a temperature increase of 1 °C/min. A steel plate and plate 
geometry of 25 mm diameter with a solvent trap were used for the temperature sweep 
studies. All rheological experiments were carried out in triplicate.
X-ray Photoelectron Spectroscopy.
The presence of nSi in the hydrogel, as well as the formation of a physically cross-linked 
network between nSi and DNA backbone, was analyzed using XPS. A PHI 5000 VersaProbe 
II ultrahigh vacuum (1 × 10−9 bar) apparatus with an Al Kα X-ray source and a 
monochromator was used to obtain the XPS spectra. Freeze-dried samples were used for all 
the measurements. An X-ray beam size of 100 μm was used for all the tests. The survey 
spectra were recorded with a pass energy (PE) of 117 eV, a step size of 1 eV, and a dwell 
time of 20 ms. In contrast, a PE of 23.5 eV, a step size of 0.05 eV, and a dwell time of 20 ms 
were used to record the high-energy resolution spectra of O 1s, N 1s, and P 2p for the 0% 
nSi and 0.5% nSi hydrogel. Analyzer’s focal point was located by performing Auto-z (i.e., 
automated height adjustment to the highest intensity) before each measurement. The optimal 
signal-to-noise ratio was obtained by adjusting the number of average sweeps for each 
element (average number of sweeps was 1–20). All the raw data were processed and 
deconvoluted by Multipak peak fitting software version 2.3.15.
Coating of a Bone Allograft.
A human bone allograft cut from the hip bone (Curasan Inc., USA) was dip coated with the 
0.5% nSi hydrogel. Briefly, the bone graft was immersed in the reaction mixture before 
gelation. The graft was removed from the solutions after coating, and the gel was allowed to 
form at room temperature. To study the integrity of the coating over time, the coated 
allograft was soaked in PBS with 1% penicillin/streptomycin (Thermo-Fischer Scientific, 
USA) and maintained at 37 °C for 10 days. The PBS solution was changed every alternate 
day. After 10 days, the graft was removed from the PBS solution and freeze-dried before 
SEM imaging. A bone allograft without any coating was imaged as well as a reference.
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Bioprinting of the Nanocomposite Hydrogel.
The 0.5% nSi nanocomposite hydrogel was bioprinted to well-defined structures using an 
extrusion-based printing method. The structures were designed utilizing a repetier—host 
software and loaded via computer-aided manufacturing software. An Inkredible benchtop 
3D bioprinter (Cellink, Sweden) was used to print the constructs. Printing was done at room 
temperature, using a 25 G needle (inner diameter = 0.25 mm). An XY-plane speed of 39 
mm/s and an extrusion speed of 10 mm/s were employed to achieve a layer thickness of 0.2 
mm. Phase contrast images of the printed construct were obtained by using a bright-field 
microscope EVOS cell imaging system (Thermo-Fischer Scientific, USA).
In Vitro Dexamethasone Release Studies.
Release studies were performed using slide-a-lyzer mini dialysis units with a molecular 
weight cut off of 2 kDa (Thermo Fisher Scientific Inc., Waltham, MA, USA).70 The dialysis 
cup was filled with 200 μL of each respective hydrogel. Experiments were conducted in a 
48-well plate filled with 400 μL of PBS placed in a shaker incubator at 37 °C and a rotating 
speed of 60 rpm. The entire volume was withdrawn every 24 hours up to 10 days until a 
plateau was reached. The absorbance of Dex was detected using a Cytation 5 plate reader 
(BioTek, USA) at 240 nm. A standard calibration curve in the range of 0.01 to 0.4 mg/mL 
was used to quantify the amount of Dex released. The percentage of Dex was calculated as 
the mean ± standard deviation (n = 3). Hydrogels without the drug were also tested at 260 
nm to detect any possible degradation and to assess if DNA chains were leaching out.
In Vitro Biocompatibility Studies.
Human adipose-derived stem cells (RoosterBio, USA) were grown in Invitrogen α-
minimum essential medium (α-MEM) with 10% fetal bovine serum (FBS) (Thermo-Fischer 
Scientific, USA) and 1% penicillin/streptomycin (basal media). The cells were maintained at 
37 °C and 5% CO2. Passages 3–5 were used for all the experiments. To evaluate the 
hydrogel biocompatibility, hASCs were cultured up to confluency in a 48-well plate and 
then exposed to the different nanocomposite hydrogel formulations. The gels were delivered 
to the cells after being dispersed in a PBS solution (20 μL of gel/200 μL of basal media). 
Subsequently, an MTS assay (Promega, USA) was performed after 24 and 72 h to test the 
biocompatibility of the hydrogels. As a positive control, the cells were grown under serum 
starvation conditions to disrupt cell growth. Furthermore, live/dead cell staining assay was 
performed to visualize cell viability after 24 h of contact with the nanocomposite systems. 
The hydrogel concentrations used for live/dead staining were similar to those used in the 
MTS studies. Live cells were stained with calcein AM as green, whereas the dead cells were 
stained with ethidium homodimer-1 as the red color. The effect of the formulated hydrogels 
on cell morphology and spreading was investigated by staining the actin filaments as well as 
the cell nuclei. The hASCs were seeded into chamber slides (4 × 104/mL) and allowed to 
grow in basal media for 24 h. Subsequently, the cells were treated with the different 
nanocomposite hydrogels (20 μL of gel/200 μL of basal media). After 24 and 72 h of 
exposure, the cells were fixed in 4% paraformaldehyde for 5 min at 37 °C followed by 
permeabilization with 0.1% Triton-X100 for 10 min at room temperature. 
Immunofluorescence images were obtained after counterstaining the F-actin with phalloidin-
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AlexaFluor488 (Invitrogen, USA) and nuclei with diamidino-2-phenylindole dilactate 
(DAPI, Invitrogen, USA).
In Vitro Differentiation.
The osteogenic differentiation of hASCs was investigated to evaluate the retained efficacy of 
Dex after being released. The hASCs (4 × 104/mL) were seeded into 24-well plates and 
allowed to grow in basal media for 24 h. The culture medium was changed after 24 h as per 
the respective groups. Four different groups used for the study were labeled as (1) negative 
control (Neg ctrl), hASCs cultured in basal media containing α-MEM with 10% FBS and 
1% penicillin/streptomycin; (2) OC, hASCs cultured in osteoconductive media (α-MEM 
supplemented with 10% FBS, 50 μM ascorbic acid-2-phosphate, and 10 mM β-
glycerophosphate); (3) +nSi, hASCs cultured in osteconductive media and supplemented 
with the Dex released from 0.5% nSi hydrogel; and (4) positive control (Pos ctrl), hASCs 
cultured in osteoinductive media (α-MEM, supplemented with 10% of FBS and 1% of 
penicillin/streptomycin, 50 μM ascorbic acid-2-phosphate, 10 mM β-glycerophosphate, and 
10 nM of Dex). The final concentration of Dex in the +nSi group was maintained at 10 nM. 
The culture media of all the groups were changed every alternate day. The presence of ALP 
was visualized by staining the cells at respective time points following the standard protocol 
provided by the manufacturer (alkaline phosphatase kit, Sigma-Aldrich, USA). The enzyme 
activity was further quantified by an alkaline phosphatase fluorometric assay kit (Abcam, 
ab83371, USA), by measuring the fluorescence intensity at ex/em = 360/440 nm. Alizarin 
red S staining was performed following previously described protocols.71 Briefly, cells were 
fixed in 4% paraformaldehyde after being washed with PBS. Then they were incubated with 
2% Alizarin red S (ScienCell Research Laboratories, USA) for 5 min. Excess stain was 
removed by washing with deionized water before taking the images of the stained samples. 
The calcium concentration was quantified by a colorimetric calcium assay kit (Cayman 
Chemical, USA) as per the manufacturer’s protocol.
Finally, qPCR analysis was performed to estimate the gene expression of several osteoblast 
markers including ALP, COLA1, BGLAP, and BSP using GAPDH as the control gene. 
Groups tested were the same as described above. mRNA from the respective samples were 
extracted at day 14. Three different samples were tested for each group (n = 3). The ΔΔCt 
relative method was used to calculate the fold increase expression. The experimental results 
were normalized based on the gene expression levels obtained for the group of hASCs 
cultured in basal media.
Animals and Surgical Procedures for Implantation of Nanocomposite Hydrogels.
The animal surgeries for in vivo experiments were performed at the University of Kansas 
Medical Center, Kansas City, Kansas. All experimental procedures with animals were 
approved by the Animal Care and Use Committee. A rat calvarial defect model with 8–9 
weeks old female Sprague—Dawley rats were used in this study. All surgical procedures 
were performed under sterile conditions. The periosteum of the rats was removed after 
making a longitudinal skin incision over the midsagittal suture of the skull and a precise 
dissection. Then a dental burr was used to create an 8 mm diameter full thickness defect in 
the parietal bone. During the process, the wound area was constantly rinsed with normal 
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saline to prevent overheating and remove any bone debris from the defect region. This was a 
very important step in this procedure for evaluating the formation of new bone within the 
cranial bone defect. The bone defects were filled with 0.5% nSi hydrogel (gel), 0.5%nSi 
hydrogel + dexamethasone (gel + Dex), or left untreated (negative control). An amount of 
0.3 mg of Dex was used per animal, and six animals were used per group. The surgical 
wound was thereafter closed with a 5-0 nylon suture as previously described, and the day of 
surgery was designated as day “0”.72-74 Animals were sacrificed at 28 days after 
implantation to harvest the operated cranial bones for histological analysis. A time frame of 
28 days was chosen as an end-point for this study based on our our previous studies which 
had demonstrated bone healing in 8 mm rat cranial defects 28–30 days after implantation of 
effective bone repair biomaterials.72-74
Histology Analysis.
The cranial samples (containing the bone defect and the surrounding host bone) were fixed 
in 10% buffered formalin (American MasterTech, Lodi, CA), decalcified in 25% formic acid 
(Sigma, St. Louis, MO), and embedded in paraffin (Leica Biosystems, Richmond, IL), 
sectioned at 5 μm, and stained with H&E to observe the cellular and tissue response to 
various treatments in the cranial bone defects. Six animals per group were examined.
Statistical Analysis.
Statistical analysis was carried out to determine whether a significant difference existed 
between the experimental groups. One-way analysis of variance (ANOVA) followed by 
Tukey’s multiple comparison tests was performed. GraphPad Prism 5 was used for all the 
statistical analyses. A p value less than 0.05 was used to identify statistical significance (*p 
< 0.05, **p < 0.01, ***p < 0.001).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Schematic representation of the design strategy for the development of multifunctional 
nanocomposite hydrogels. DNA—nSi injectable hydrogels are formed via a two-step 
gelation method. The first step consists of an intermediate weak gel (pregel) formation by 
heating and subsequent cooling of double-stranded DNA. The denaturation of double-
stranded DNA followed by rehybridization in a random fashion facilitates the development 
of interconnections between adjacent DNA strands (type A network points) via 
complementary base pairing. Introduction of nSi in the second step of the gelation process 
increases the number of network points (type B) via electrostatic interaction with the DNA 
backbone, resulting in a shear-thinning injectable hydrogel.
Basu et al. Page 22














Morphology, composition, and shear-thinning characteristics of the nanocomposite 
hydrogels. (a) TEM image displaying the nSi dispersion in water (scale bar = 100 nm). (b) 
Image showing the injection of the blue colored hydrogel through a 22 gauge surgical 
needle. (c) Viscosity vs shear rate plots illustrate an increase in the viscosity due to the 
presence of nSi. All the formulations display the typical shear-thinning behavior with a 
reduction in the viscosity as the shear rate increases. (d) Scanning electron microscopy 
images of the DNA-based hydrogel showing a highly porous structure. The inclusion of nSi 
reduces the pore size of the hydrogel network (scale bar =100 μm). (e) Measurement of pore 
diameters by ImageJ, displaying a significant decrease in pore size of the hydrogel network 
upon addition of nSi. Results are shown as mean ± standard deviation (n = 50) (*p < 0.05, 
**p < 0.01, ***p < 0.001). (f) Energy-dispersive X-ray spectra of 0% nSi (i.e., DNA gel 
without nSi) and (g) 0.5% nSi (i.e., DNA gel with 0.5% nSi) indicate the presence of Si and 
Mg in the nanocomposite hydrogel. (h) XPS of 0.5% nSi hydrogels confirming the presence 
of nSi in the nanocomposite hydrogel. The Si 2p peak was visible at around 100 eV.
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Mechanical and structural characterization of nanocomposite hydrogels as injectable 
materials. (a) Tan δ (G″/G′) profiles for the nanocomposite hydrogels over a range of 
frequency from 0.01 to 10 Hz. (b) Frequency sweep experiments performed in the range of 
0.01 to 10 Hz indicate an increase in storage modulus as the concentration of nSi was 
increased. (c) Plot of yield stress as a function of nSi concentration. Results are reported as 
mean ± standard deviation (n = 3) (***p < 0.001). (d) Recovery data obtained by monitoring 
the storage modulus of the nanocomposite hydrogels while subjecting them to alternating 
high (100%) and low (1%) strain conditions. Both 0% nSi (i.e., DNA gel without nSi) and 
0.5% nSi (i.e., DNA gel with 0.5% nSi) exhibited more than 95% recovery. (e) Temperature 
sweeps carried out from 25 to 45 °C. Tan δ values displayed no significant changes in the 
range of experimental temperatures. (f) Fourier transform infrared spectra of the DNA 
hydrogel with and without nSi. The highlighted bands (asymmetric stretching and bending 
of phosphate group) indicate the electrostatic interactions between the nanosilicate edges 
and DNA.
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XPS analysis of the nanocomposite DNA-based hydrogel. Comparison of high-resolution 
XPS spectra of 0% nSi (i.e., DNA gel without nSi) and 0.5% nSi (i.e., DNA gel with 0.5% 
nSi) for (a) oxygen (O 1s), (b) phosphorus (P 2p), and (c) nitrogen (N 1s). Comparison of 
the deconvoluted peaks of (d) O 1s, (e) P 2p, and (f) N 1s for both 0% nSi and 0.5% nSi 
systems. The experimental data points are shown as solid black lines. The rearrangement of 
the O 1s peak components and the shift of P 2p peak confirmed the presence of attractive 
electrostatic interactions between the oxygen atom of phosphate anion (PO2−) and silicate 
nanodisks. (g) Proposed mechanism for physical cross-linking between the DNA backbone 
and silicate nanodisks.
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In vitro biocompatibility and controlled release properties of the physically cross-linked 
hydrogels. (a) MTS assay at 24 and 72 h of hASCs in contact with the nanocomposite 
hydrogels revealed no significant difference in cell viability irrespective of the concentration 
of nSi used. Cells grown under serum-starved conditions served as a positive control. (b) 
Representative fluorescence images of actin stained with Alexa Fluor 488 Phalloidin (green) 
and nuclei stained with DAPI (blue), of hASCs after 72 h of contact with the hydrogels. 
Cells grown under serum-starved conditions served as a positive control (scale bar = 400 
μm). (c) Comparison of release profiles of Dex from DNA hydrogels without nSi and the 
nanocomposite systems over a period of 10 days. Results are shown as the mean ± standard 
deviation (n = 3). (d) Half-release time (t1/2) of Dex as a function of nSi concentration 
confirmed the sustained release behavior of the nanocomposite hydrogels. (e) Viscosity vs 
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shear rate plots of hydrogels loaded with the drug confirming the retention of shear-thinning 
behavior after Dex loading. (f) Schematic and corresponding images displaying a bone 
allograft before and after coating with the nanocomposite DNA-based hydrogel. (g) Time-
lapse SEM micrographs of the allograft showing the erosion of the coating from the graft 
surface after 10 days of study (scale bar = 500 μm).
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Evaluation of in vitro and in vivo efficacy of the drug-loaded hydrogel for osteogenic 
differentiation. (a) Images of ALP staining of hASCs after 7 and 14 days of Dex treatment. 
Both the Dex-treated group (+nSi) and cells grown in osteoinductive media (pos ctrl) show 
high levels of ALP, representing osteogenic differentiation of hASCs (scale bar = 400 μM). 
(b) Alizarin red staining of hASCS after 7 and 14 days to detect the calcium deposition 
(scale bar = 400 μM). Intense red staining signifies osteogenic differentiation of hASCs. (c) 
ALP quantification demonstrated levels of ALP expression in the Dex-treated group 
significantly higher than those of the cells grown in basal media (neg ctrl) and 
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osteoconductive media (OC). (d) Quantification of the deposited calcium confirmed 
significantly higher amounts of calcium in the Dex-treated group as compared to that in neg 
ctrl and OC. (e) qPCR analysis of different osteogenic markers after 14 days of Dex 
treatment. The fold expression increase of ALP and COLA1 was assessed following the 
ΔΔCt relative method. Results are shown as mean ± standard deviation (n = 3) (*p < 0.05, 
**p < 0.01, ***p < 0.001). Basal media, α-MEM, 10% FBS, 1% penicillin/streptomycin; 
osteoconductive media, α-MEM, 10% FBS, 1% penicillin/streptomycin, 50 μM ascorbic 
acid-2-phosphate, 10 mM β-glycerophosphate; osteoinductive media, α-MEM, 10% FBS, 
1% penicillin/streptomycin, 50 μM ascorbic acid-2-phosphate, 10 mM β-glycerophosphate, 
and 10 nM Dex. (f) Schematic representation of the injection of the hydrogel (0.5% nSi + 
Dex) into a rat cranial defect and a representative image of the hematoxylin and eosin 
(H&E)-stained rat calvarial defect region. (g) H&E staining of tissue sections obtained from 
the rat calvarial defects 4 weeks post-treatment. Images were taken at two different 
magnifications (5× top row and 20× bottom row). Scale bars are 200 μm for the 5× images 
and 50 μm for the 20× images. The new bone formation in the central region of the cranial 
defects are marked in the images. The sections enclosed within the dotted lines are 
magnified in the bottom row images (n = 6).
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